8-K 1 v442023_8-k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): | June 10, 2016

STAAR Surgical Company
__________________________________________

(Exact name of registrant as specified in its charter)

Delaware | 0-11634 | 95-3797439
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.)
1911 Walker Ave, Monrovia, California |  | 91016
(Address of principal executive offices) |  | (Zip Code)

Registrant’s telephone number, including area code: | 626-303-7902

Not Applicable

______________________________________________

Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01 | Regulation FD Disclosure.

STAAR Surgical Company’s Chief Executive Officer, Caren Mason, and Chief Financial Officer, Stephen Brown, will give presentations to investors on June 10, 2016. A copy of the slide presentation they will use in their presentations is furnished as Exhibit 99.1 to this Report, and is incorporated herein by this reference.

The information furnished herewith pursuant to Item 7.01 of this Current Report, including Exhibit 99.1, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in Item 7.01 of this Current Report shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in the filing.

Item 9.01 | Financial Statements and Exhibits

(d) Exhibits

Exhibit No. | Description
99.1 | Slide Presentation dated June 10, 2016.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

STAAR Surgical Company |
June 10, 2016 | By: | /s/ Caren Mason |
|  | Caren Mason |
|  | President and Chief Executive Officer |